Skip to main content
NCBI home page
Antimicrobial Agents and Chemotherapy logoLink to Antimicrobial Agents and Chemotherapy
. 1985 Oct;28(4):578–580. doi: 10.1128/aac.28.4.578

Activity of arildone with or without interferon against acute hemorrhagic conjunctivitis viruses in cell culture.

M P Langford, D J Carr, M Yin-Murphy
PMCID: PMC180309  PMID: 2416272

Abstract

Arildone (WIN 38020; 4-[6-(2-chloro-4-methoxyphenoxy)hexyl]-3,5-heptanedione) inhibited the infectivity of acute hemorrhagic conjunctivitis viruses in tissue culture. Arildone did not inhibit interferon (IFN) production or IFN activity. Treatment of cultures with combinations of arildone and IFN resulted in an additive inhibition of acute hemorrhagic conjunctivitis virus production.

Full text

PDF
578

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Kim K. S., Sapienza V. J., Carp R. I. Antiviral activity of arildone on deoxyribonucleic acid and ribonucleic acid viruses. Antimicrob Agents Chemother. 1980 Aug;18(2):276–280. doi: 10.1128/aac.18.2.276. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Kono R. Apollo 11 disease or acute hemorrhagic conjunctivitis: a pandemic of a new enterovirus infection of the eyes. Am J Epidemiol. 1975 May;101(5):383–390. doi: 10.1093/oxfordjournals.aje.a112106. [DOI] [PubMed] [Google Scholar]
  3. Langford M. P., Barber J. C., Sklar V. E., Clark S. W., 3rd, Patriarca P. A., Onarato I. M., Yin-Murphy M., Stanton G. J. Virus-specific, early appearing neutralizing activity and interferon in tears of patients with acute hemorrhagic conjunctivitis. Curr Eye Res. 1985 Mar;4(3):233–239. doi: 10.3109/02713688509000855. [DOI] [PubMed] [Google Scholar]
  4. Langford M. P., Villarreal A. L., Stanton G. J. Antibody and interferon act synergistically to inhibit enterovirus, adenovirus, and herpes simplex virus infection. Infect Immun. 1983 Jul;41(1):214–218. doi: 10.1128/iai.41.1.214-218.1983. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Langford M. P., Weigent D. A., Stanton G. J., Baron S. Virus plaque-reduction assay for interferon: microplaque and regular macroplaque reduction assays. Methods Enzymol. 1981;78(Pt A):339–346. doi: 10.1016/0076-6879(81)78139-4. [DOI] [PubMed] [Google Scholar]
  6. Langford M. P., Yin-Murphy M., Ho Y. M., Barber J. C., Baron S., Stanton G. J. Human fibroblast interferon in tears of patients with picornavirus epidemic conjunctivitis. Infect Immun. 1980 Sep;29(3):995–998. doi: 10.1128/iai.29.3.995-998.1980. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. McKinlay M. A., Miralles J. V., Brisson C. J., Pancic F. Prevention of human poliovirus-induced paralysis and death in mice by the novel antiviral agent arildone. Antimicrob Agents Chemother. 1982 Dec;22(6):1022–1025. doi: 10.1128/aac.22.6.1022. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. McSharry J. J., Caliguiri L. A., Eggers H. J. Inhibition of uncoating of poliovirus by arildone, a new antiviral drug. Virology. 1979 Sep;97(2):307–315. doi: 10.1016/0042-6822(79)90342-8. [DOI] [PubMed] [Google Scholar]
  9. Stanton G. J., Langford M. P., Baron S. Effect of interferon, elevated temperature, and cell type on replication of acute hemorrhagic conjunctivitis viruses. Infect Immun. 1977 Nov;18(2):370–376. doi: 10.1128/iai.18.2.370-376.1977. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Wadia N. H., Katrak S. M., Misra V. P., Wadia P. N., Miyamura K., Hashimoto K., Ogino T., Hikiji T., Kono R. Polio-like motor paralysis associated with acute hemorrhagic conjunctivitis in an outbreak in 1981 in Bombay, India: clinical and serologic studies. J Infect Dis. 1983 Apr;147(4):660–668. doi: 10.1093/infdis/147.4.660. [DOI] [PubMed] [Google Scholar]

Articles from Antimicrobial Agents and Chemotherapy are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES